| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 31 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $418.2K | - | |
| CFO | 26.0K | $181.2K | - | |
| Dir | 7.0K | $48.8K | - | |
| Dir | 7.0K | $48.8K | - | |
| Dir | 7.0K | $48.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 17, 2017 | Kurkijarvi Kalevi | Director | Sell | 2,000 | $25.25 | $50,500.00 | -5.0% | |
| Apr 13, 2017 | Neff Thomas B | Chief Executive Officer | Sale+OE | 38,636 | $24.79 | $957,670.36 | -0.4% | |
| Apr 4, 2017 | Neff Thomas B | Chief Executive Officer | Sale+OE | 38,636 | $23.92 | $924,122.96 | -0.6% | |
| Mar 21, 2017 | Neff Thomas B | Chief Executive Officer | Sale+OE | 38,636 | $24.34 | $940,305.00 | -0.3% | |
| Mar 15, 2017 | Neff Thomas B | Chief Executive Officer | Sale+OE | 38,636 | $25.07 | $968,471.04 | -0.4% | |
| Mar 14, 2017 | Yu K Peony | Chief Medical Officer | Sell | 7,851 | $25.41 | $199,458.23 | -1.7% | |
| Mar 10, 2017 | Cotroneo Pat | VP, Finance And CFO | Sell | 7,851 | $25.30 | $198,630.30 | -4.7% | |
| Mar 2, 2017 | Cotroneo Pat | VP, Finance And CFO | Sale+OE | 6,500 | $26.00 | $169,000.00 | -2.4% | |
| Feb 16, 2017 | Kurkijarvi Kalevi | Director | Sell | 2,000 | $24.45 | $48,900.00 | -4.8% | |
| Feb 14, 2017 | Neff Thomas B | Chief Executive Officer | Sale+OE | 38,636 | $23.94 | $924,765.20 | -0.6% |